Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Nimvastid 1.5 mg hard capsules.
Nimvastid 3 mg hard capsules.
Nimvastid 4.5 mg hard capsules.
Nimvastid 6 mg hard capsule.
| Pharmaceutical Form |
|---|
|
Hard capsule. Nimvastid 1.5 mg hard capsules: White to almost white powder in a capsule with yellow cap and yellow body. Nimvastid 3 mg hard capsules: White to almost white powder in a capsule with orange cap and orange body. Nimvastid 4.5 mg hard capsules: White to almost white powder in a capsule with brownish red cap and brownish red body. Nimvastid 6 mg hard capsules: White to almost white powder in a capsule with a brownish red cap and orange body. |
Nimvastid 1.5 mg hard capsules: Each hard capsule contains rivastigmine hydrogen tartrate equivalent to 1.5 mg rivastigmine.
Nimvastid 3 mg hard capsules: Each hard capsule contains rivastigmine hydrogen tartrate equivalent to 3 mg rivastigmine.
Nimvastid 4.5 mg hard capsules: Each hard capsule contains rivastigmine hydrogen tartrate equivalent to 4.5 mg rivastigmine.
Nimvastid 6 mg hard capsules: Each hard capsule contains rivastigmine hydrogen tartrate equivalent to 6 mg rivastigmine.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Rivastigmine |
Rivastigmine is an acetyl- and butyrylcholinesterase inhibitor of the carbamate type, thought to facilitate cholinergic neurotransmission by slowing the degradation of acetylcholine released by functionally intact cholinergic neurones. Thus, rivastigmine may have an ameliorative effect on cholinergic-mediated cognitive deficits in dementia associated with Alzheimer’s disease and Parkinson’s disease. |
| List of Excipients |
|---|
|
Capsule content: Microcrystalline cellulose Capsule shell: Titanium dioxide (E171) |
Blister pack (PVC/PVDC/Alu-foil): 14, 28, 30, 56, 60 or 112 hard capsules in a box.
HDPE container: 200 or 250 hard capsules in a box.
Not all pack sizes may be marketed.
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
14 hard capsules: EU/1/09/525/001
28 hard capsules: EU/1/09/525/002
30 hard capsules: EU/1/09/525/003
56 hard capsules: EU/1/09/525/004
60 hard capsules: EU/1/09/525/005
112 hard capsules: EU/1/09/525/006
200 hard capsules: EU/1/09/525/047
250 hard capsules: EU/1/09/525/007
Date of first authorisation: 11/5/2009
Date of latest renewal: DD month YYYY
| Drug | Countries | |
|---|---|---|
| NIMVASTID | Austria, Cyprus, Germany, Estonia, Spain, Finland, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
